INTERNATIONAL PATENT: DAEWOONG THERAPEUTICS, INC., 주식회사 대웅테라퓨틱스 FILES APPLICATION FOR "COMPOSITION COMPRISING REBAMIPIDE WITH IMPROVED STABILITY AND DOSING CONVENIENCE"

GENEVA, April 14 -- DAEWOONG THERAPEUTICS, INC. (401-ho, A-dong, 27 Dongtancheomdansaneop 1-roHwaseong-sGyeonggi-do 18469), 주식회사 대웅테라퓨틱스 (경기도화성시동탄첨단산업1로 27, A동 401호) filed a patent application (PCT/KR2025/010009) for "COMPOSITION COMPRISING REBAMIPIDE WITH IMPROVED STABILITY AND DOSING CONVENIENCE" on Jul 09, 2025. With publication no. WO/2026/075334, the details related to the patent application was published on Apr 09, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World ...